A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users.

Authors:
  • SMSteve Martino
    Steve Martino
  • SBSamuel A. Ball
    Samuel A. Ball
  • TFTami Frankforter
    Tami Frankforter
  • LALuis M. Anez
    Luis M. Anez
  • MPManuel Paris
    Manuel Paris
  • LSLourdes Suarez-Morales
    Lourdes Suarez-Morales
  • JSJosé Szapocznik
    José Szapocznik
  • WMWilliam R. Miller
    William R. Miller
  • CRCarmen Rosa
    Carmen Rosa
  • JMJulie Matthews
    Julie Matthews

Abstract
Hispanic individuals are underrepresented in clinical and research populations and are often excluded from clinical trials in the United States. Hence, there are few data on the effectiveness of most empirically validated therapies for Hispanic substance users. The authors conducted a multisite randomized trial comparing the effectiveness of 3 individual sessions of motivational enhancement therapy with that of 3 individual sessions of counseling as usual on treatment retention and frequency of substance use; all assessment and treatment sessions were conducted in Spanish among 405 individuals seeking treatment for any type of current substance use. Treatment exposure was good, with 66% of participants completing all 3 protocol sessions. Although both interventions resulted in reductions in substance use during the 4-week therapy phase, there were no significant Treatment Condition x Time interactions nor Site x Treatment Condition interactions. Results suggest that the individual treatments delivered in Spanish were both attractive to and effective with this heterogeneous group of Hispanic adults, but the differential effectiveness of motivational enhancement therapy may be limited to those whose primary substance use problem is alcohol and may be fairly modest in magnitude.
Funding Information
  • National Institute on Drug Abuse (U10 DA13038)
  • University of Miami (U10 DA13720)
  • University of New Mexico (U10 DA015833)
  • Columbia University (U10 DA13035)
  • Oregon Health and Sciences University (U10 DA13036)
  • Clinical Trials Network (Cooperative agreement U10 DA13716)

This publication has 15 references indexed in Scilit: